Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists

Funding Agency:
Pfizer Inc.

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.

Through this RFP, it is our intent to support programs for dermatologists and allergists on new and emerging therapies for moderate-to-severe atopic AD. Particular areas of interest include, but are not limited to:

• Help dermatologists and allergists stay current with the new emerging data for advanced therapies under development for moderate-to-severe atopic dermatitis

• Provide dermatologists and allergists with an overview of the benefit and risk profile of new and emerging therapies such as JAK inhibitors for moderate-to-severe atopic AD

• Improve dermatologists and allergists understanding of the importance of vaccination in the care of patients with atopic dermatitis, especially with the use of JAK inhibitors and other immunosuppressive agents

Grant Application due date: April 7, 2021

Agency Website

Eligibility Requirements

Geographic Scope: United States

• The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project. • For projects offering continuing education credit, the requesting organization must be accredited.



Amount Description

Individual projects requesting up to $250,000 will be considered. The estimated total available budget related to this RFP is $500,000.

Funding Type





Curriculum Development
Medical - Clinical Science
Medical - Translational

External Deadline

April 7, 2021